Rankl expression and chromosome 13 deletions in cell lines from patients with multiple myeloma and osteosarcoma

Rankl expression and chromosome 13 deletions in cell lines from patients with multiple myeloma and osteosarcoma

Bibliographic Details
Main Author:	Spary, Lisa Kate
Published:	University of the West of England, Bristol 2007
Subjects:	616.99471042
Online Access:	http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.444485

Similar Items

Gene expression profiling of osteosarcoma
by: Leonard, Pauline Catherine
Published: (2006)

Chromosome 13q14 deletions in Multiple Myeloma at Chris-Hani Baragwanath Hospital
by: Pheeha, Sekgokwa Teboho Stella
Published: (2010)

The study of expressed genes in multiple myeloma
by: Dring, Ann Marie
Published: (2004)

Balanced chromosomal translocations and chromosome 13 rearrangements in human breast cancer cell lines
by: Kranjac, Tanja
Published: (2005)

Pharacogenetics in multiple Myeloma
by: Johnson, David Christopher
Published: (2010)

The role of chromosomal deletions and translocations in the pathogenesis of the myeloproliferative disorders
by: Huntly, Brian James Patrick
Published: (2003)

The genetic characterisation of multiple myeloma
by: Elnenaei, Manal Osama
Published: (2002)

The Genetics of Asthma and Chromosome 13
by: Holt, Richard
Published: (2007)

A microarray approach to detect chromosome 18 deletions in colorectal cancer
by: Trickett, Jonathan P.
Published: (2007)

Drug resistance mechanisms in multiple myeloma
by: Scott, F. M.
Published: (1998)

Chromosome 6q16-21 deletions in acute lymphoblastic leukaemia
by: Sorour, Amani Fouad Abdel Halim
Published: (2002)

Chromosome 13 abnormalities in myeloproliferative diseases
by: Macdonald, Donald Hugh Charles
Published: (2003)

Role of chromosome 13 in colorectal cancer
by: Sivarajasingham, Nalayini Swarnarupa
Published: (2004)

Characterisation of a Novel Homozygous Deletion Cluster on the Long Arm of Chromosome 3
by: Hargrave, Darren Russell
Published: (2010)

An investigation of proteasome activity and inhibition in multiple myeloma
by: Crawford, L.
Published: (2006)

Prognostic factors in paraproteinaemia, treatment of multiple myeloma
by: Al-Rubei, Kastal J.
Published: (1980)

Genetic changes in the development of multiple myeloma
by: Chiecchio, Laura
Published: (2010)

Genotoxicity and functionality assessment of a bone marrow stromal cell line following chemotherapy exposure in an in vitro model of multiple myeloma
by: Andrews, S. W.
Published: (2017)

Characterisation of the atopy locus on chromosome 13q14
by: Anderson, Gavin George
Published: (2001)

Functional annotation of the 'Del(13)Svea36H' region of mouse chromosome 13
by: Willoughby, Catherine
Published: (2006)

Generation and characterisation of tumour-associated regulatory T cells in multiple myeloma
by: Feyler, Sylvia
Published: (2013)

The role of the RANK ligand/osteoprotegerin system in the development of multiple myeloma
by: De Leenheer, Evy
Published: (2005)

A study of c-myc translational regulation in multiple myeloma
by: Paulin, Fiona E. M.
Published: (1997)

Prior medical history, drug exposure and risk of multiple myeloma
by: McShane, Charlene
Published: (2015)

Enhancement of death receptor-mediated apoptosis in multiple myeloma cells
by: Arhoma, Amal Ali
Published: (2017)

The role of interleukin-17 and RANKL in the regulation of bone destruction in arthritis
by: Abusrer, Salma
Published: (2004)

Chromosome 11q13 deletion syndrome
by: Yu-Seon Kim, et al.
Published: (2016-11-01)

Fine mapping of chromosome 10q deletions and candidate gene analysis in mycosis fungoides and Sezary syndrome
by: Wain, Elisabeth Mary
Published: (2005)

Mapping and mutational analysis of chromosome 11q12-13
by: Coyle, Elizabeth
Published: (1995)

Chromosome rearrangements in breast tumour cell lines
by: Davidson, J. M.
Published: (2001)

Chromosome abnormalities in breast cancer cell lines
by: Morris, Joanna Siriol
Published: (1997)

Immune suppression in multiple myeloma : strategies to overcome NK cell inhibition
by: Giunti, Giulia
Published: (2014)

APRIL based therapeutic strategies to target BCMA and TACI in multiple myeloma
by: Lee, L. S. H.
Published: (2017)

Deletion of Chromosomal Region 8p21 Confers Resistance to Bortezomib and Is Associated with Upregulated Decoy TRAIL Receptor Expression in Patients with Multiple Myeloma.
by: Adil Doganay Duru, et al.
Published: (2015-01-01)

Association of Chromosomal Translocation and MiRNA Expression with The Pathogenesis of Multiple Myeloma
by: Najmaldin Saki, et al.
Published: (2014-06-01)

A Study of Osteosarcoma
by: Camblin, J. G.
Published: (1975)

Evaluation of a patient educational booklet for the management of peripheral neuropathy in multiple myeloma
by: Clarke, Helen Louise
Published: (2011)

Erythropoietin-induced genes and the erythropoietin receptor : their possible role in the pathogenesis of multiple myeloma
by: Stewart, J. P.
Published: (2003)

The role of APRIL in promoting cell cycle progression and drug resistance in multiple myeloma
by: Quinn, J.
Published: (2013)

Malignant Paraproteinaemia : A Clinical and Pathological Review of Multiple Myeloma and Related Diseases
by: Mason, D. Y.
Published: (1976)

Cannot write session to /tmp/vufind_sessions/sess_1i5j9di65pibk9fp91he5btr1g